semaglutide risk of cancer Assessment Thyroid Carcinogenic and Safety Profile of GLP1-RA (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review Drugs like Ozempic and Wegovy

Its a first-in-class dual agonist targeting both GLP-1 and GIP receptors, setting it apart from single-receptor peptides like semaglutide

*The % Daily Value (DV) tells how much

The most famous female tennis player of our time is on a GLP-1 drug

Cortisol levels and suicidal behavior: a meta-analysis

If you have diabetes along with chronic kidney disease, you might wonder: Is this popular drug good for your kidneys or not

Participants were randomized to receive either semaglutide or placebo in a 2:1 ratio, combined with a low-calorie diet for the first 8 weeks, followed by intensive behavioral therapy for 68 weeks, including 30 counseling visits